• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Riociguat(625115-55-1)
Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate
2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)
4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-
1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

UK pledges 100 million pounds to scale up COVID-19 vaccine production

expresspharmaJuly 27, 2020

Tag: UK , COVID-19 vaccine , Manufacturing

The nation announced set up for a new Cell and Gene Therapy Catapult Manufacturing Innovation Centre.

Britain said it will provide 100 million pounds ($127 million) of funding for a facility to scale up the manufacturing of vaccines for COVID-19.

“This new Cell and Gene Therapy Catapult Manufacturing Innovation Centre, alongside crucial investment in skills, will support our efforts to rapidly produce millions of doses of a coronavirus vaccine while ensuring the UK can respond quickly to potential future pandemics,” Business Secretary Alok Sharma said in a statement.


Previous:CSIR-IICT develops cost effective process technology for Favipiravir

Next:Animal replacement method for vaccine testing developed by Intravacc and Leiden University

Related News

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

PRNewswireDecember 23, 2024

SCG Cell Therapy Pte Ltd (SCG),announced the signing of a Memorandum of Understanding (MoU) with A*STAR BTI and NATi to advance RNA-based therapeutics manufacturing process development and clinical translation.

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

UK pledges 100 million pounds to scale up COVID-19 vaccine production | Pharmasources.com

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

You may like
More>>

New 7 Tons Rooftop HVAC Package Unit with Cooling Function Includes Motor for Manufacturing Plant R2

New 7 Tons Rooftop HVAC Package Unit with Cooling Function Includes Motor for Manufacturing Plant R2
Roukou Wuwei Wan

Roukou Wuwei Wan
Montelukast sodium

Montelukast sodium
Montelukast

Montelukast
collagen capsule api contract manufacturing

collagen capsule api contract manufacturing
Urokinase (UK)

Urokinase (UK)
Montelukast Sodium

Montelukast Sodium
Montelukast

Montelukast
DACHAIHUKELI

DACHAIHUKELI
Urokinase(UK)

Urokinase(UK)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service